Clinical Trial

Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry

Study acronym: PROPEL
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational registry is to assess the use and performance of Galvanize PEF technology in a real-world setting. The main questions it aims to answer are: * PEF utilization and performance * Monitor safety outcomes and inform future generation devices. Participants will undergo the PEF procedure and be followed per institutional standard of care.
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2023-05-08; most recent amendment 2026-07-01.
Status change: Not Yet Recruiting → Recruiting 2025-06-23
Status change: Terminated → Not Yet Recruiting 2025-03-20
Status change: Active, Not Recruiting → Terminated 2023-08-31
Status change: Recruiting → Active, Not Recruiting 2023-07-25
Status change: Not Yet Recruiting → Recruiting 2023-06-16
Trial Details
NCT Number NCT05851430
Lead Sponsor Galvanize Therapeutics, Inc.
Conditions Soft Tissue Lesion
Enrollment 1,000 participants
Start Date 2025-06-23
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-02